Inventia Life Science published a new peer-reviewed study in iScience evaluating the anti-invasive candidate PTU using patient-derived high-grade glioma models, including 3D invasion assays and brain assembloids combining tumor spheroids with stem-cell-derived cortical organoids.
Published
Signal category
Research & Knowledge
Quote
“In a new peer-reviewed study in iScience, researchers from the University of Sydney evaluated the anti-invasive candidate PTU using patient-derived high-grade glioma models, including 3D invasion assays and brain assembloids combining tumor spheroids with stem-cell-derived cortical organoids.”
— Inventia Life Science team
Company
Inventia Life Science
Advanced cell models made easy for high impact discovery
- Industry
- Biotechnology Research
- Location
- Alexandria, AU
- Company size
- 64 employees
Inventia Life Science is making advanced cell models easy for high impact discovery. The company’s strong foundation of fundamental research has led to the development of proprietary solutions to generate high-quality advanced cell models that are reproducible and highly consistent. Built by scientists for scientists, our intuitive solutions integrate seamlessly with existing workflows, whereas our wide range of biofunctional synthetic matrices and application-driven models make your desired assays possible.
Founded 2013